Nervgen Pharma NGEN Balance Sheet (2024-2026)

NASDAQ NGEN
$1.76 +0.01 (+0.57%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2024 Dec2025 Mar2026
Loans - Gross (Quarter) 16.64M15.14M
Assets
Current Assets
Cash & Equivalents (Quarter) 12.36M15.83M12.07M
Receivables - Net (Quarter) 0.30M0.06M
Receivables (Quarter) 0.30M0.06M0.07M
Prepaid Assets (Quarter) 0.10M0.46M2.71M
Current Assets (Quarter) 13.61M16.35M14.85M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 0.34M0.29M0.29M
Long-Term Investments (Quarter) 10.80M6.81M
Intangibles (Quarter) 0.33M0.29M0.29M
Goodwill & Intangibles (Quarter) 0.33M0.29M0.29M
Non-Current Assets (Quarter) 0.34M0.29M0.29M
Assets (Quarter) 13.95M16.64M15.14M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 3.54M3.34M4.29M
Payables (Quarter) 3.54M3.34M4.29M
Accumulated Expenses (Quarter) 0.83M0.98M
Short term Debt (Quarter) 0.01M
Current Leases (Quarter) 0.07M0.01M
Total Current Liabilities (Quarter) 12.10M14.15M11.10M
Non-Current Liabilities
Operating Leases (Quarter) 0.08M0.01M
Total Non-Current Liabilities (Quarter) 0.01M
Total Liabilities (Quarter) 12.10M16.64M15.14M
Shareholder's Equity
Total Debt (Quarter) 0.01M
Common Equity (Quarter) 1.84M2.49M4.04M
Liabilities and Shareholders Equity (Quarter) 13.95M16.64M15.14M
Retained Earnings (Quarter) -73.48M-105.24M-108.24M